New Search

If you are not happy with the results below please do another search

1383 search results for:

1252

Therapeutic drug monitoring of antiepileptic drugs

Antiepileptic drugs (AEDs) are widely used and their number is steadily increasing. Therapeutic drug monitoring of AEDs, when performed correctly, can be a valuable tool for the treating physician. This article describes the indications, limitations and pitfalls that must be observed when measuring and interpreting AED serum concentrations. by Dr Arne Reimers and Prof. Eylert […]

1254

Hemochromatosis: more common than first thought

Hereditary hemochromatosis type 1 is a disease of iron overload caused predominantly by a mutation in the homeostatic iron regulator (HFE) gene, p.Cyst282Tyr (p.C282Y). The incidence of the mutation is most common in people of northern European descent – with 1 in 8 people being carriers, making it the most common genetic condition in this […]

1255

Aqueous humour biomarkers for retinoblastoma, a pediatric ocular malignancy

For decades, attempts to biopsy or obtain fluid from eyes with retinoblastoma had been contraindicated, however recent changes in the management of retinoblastoma have allowed for safe sampling of the aqueous humour (AH) during therapy. Use of the AH as a liquid biopsy enables tumour biomarker analysis in these eyes; this has potential to dramatically […]

1258

Novel biomarkers in malignant pleural mesothelioma

Mesothelioma is a fatal cancer of mesothelial cells caused by previous asbestos exposure. Numerous biomarkers have been tested for their ability to diagnose or monitor pleural mesothelioma, but none are in routine clinical practice. This article aims to briefly outline the literature to date and future research directions. by Dr David T. Arnold and Prof. […]